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http://dx.doi.org/10.1016/j.ajic.2015.07.029Health careeassociated transmission of Clostridium difﬁcile has been well documented in long-term acute
care facilities. This article reports on 2 interventions aimed at reducing the transmission risk: multi-
disciplinary care teams and no-touch pulsed-xenon disinfection. C difﬁcile transmission rates were
tracked over a 39-month period while these 2 interventions were implemented. After a baseline period
of 1 year, multidisciplinary teams were implemented for an additional 1-year period with a focus on
reducing C difﬁcile infection. During this time, transmission rates dropped 17% (P ¼ .91). In the following
15-month period, the multidisciplinary teams continued, and pulsed-xenon disinfection was added as an
adjunct to manual cleaning of patient rooms and common areas. During this time, transmission rates
dropped 57% (P ¼ .02). These results indicate that the combined use of multidisciplinary teams and
pulsed-xenon disinfection can have a signiﬁcant impact on C difﬁcile transmission rates in long-term care
facilities.
Copyright  2015 by the Association for Professionals in Infection Control and Epidemiology, Inc.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).It has been repeatedly demonstrated in the literature that the
health care environment suffers from widespread contamination
and extended survival of multidrug-resistant organisms.1 A number
of studies have linked this environmental contamination to an
increased risk of health careeassociated infections (HAIs).2,3 For
example, a positive culture for Clostridium difﬁcile from a prior
room occupant has been found to put the subsequent patient at
2.35 times greater risk of acquiring the same infection.4 Because
there is no direct contact between the 2 patients, this prior room
occupancy risk can is attributable to environmental acquisition.5
Interventions to address HAIs in long-term acute care (LTAC)
facilities have posed unique challenges for infection prevention,
speciﬁcally in the area of enhanced environmental hygiene. Long-
term care patients have more compromised immune function
than traditional acute care patients and are more likely to bePH, DrPH, Xenex Disinfection
78216.
mons).
ich, and Stachowiak are em-
ces, LLC.
fessionals in Infection Control and
enses/by-nc-nd/4.0/).colonized with organisms such as C difﬁcile.6 Many hospitalized
patients are transferred to and from LTAC facilities, increasing the
likelihood of acquiring C difﬁcile infection in the process.7,8 Infected
patients and asymptomatic carriers can shed pathogens onto
environmental surfaces.9 If these surfaces are not properly dis-
infected, infection can be spread by direct contact or cross-
contamination by health care workers. This is especially relevant
with C difﬁcile infection, which is the leading cause of health
careeassociated diarrhea.10 This issue can be compounded in LTAC
facilities, where the average length of stay is close to a month, and
the communal design of the facilities enhances the interaction
among patients.
As a result of the well-described link between environmental
contamination and HAI acquisition, health care facilities are now
exploring new methods of interrupting transmission. Many of
these methods are based on the multidisciplinary approaches rec-
ommended in infection prevention best practice guidelines. An
additional consideration has been enhancing the effectiveness of
environmental disinfection. No-touch disinfection technologies
have been developed as an adjunct to manual cleaning practices.
The goal of these devices is to complete disinfection of surfaces thatEpidemiology, Inc. Published by Elsevier Inc. This is an open access article under the
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Fig 1. HA-CDI rates expressed per 10,000 patient days by month (July 2010-September
2014). The PX-UV arm was added to a continuing multidisciplinary team approach.
HA-CDI, Hospital-acquired Clostridium difﬁcile infection; PX-UV, pulsed-xenon ultravi-
olet light disinfection.
R. Miller et al. / American Journal of Infection Control 43 (2015) 1350-3 1351may have been missed by environmental cleaning staff. Such
technologies use hydrogen peroxide vapor, pulsed-xenon ultravi-
olet light (PX-UV), or mercury ultraviolet light (UV). There are
several outcome studies demonstrating reduced infection rates
after the implementation of PX-UV, but this evidence has been
isolated to acute care facilities.11-13 To our knowledge, no research
exists to date that describes the use of no-touch disinfection in the
LTAC setting.
The purpose of this study is to address the effectiveness of 2
hospital-associated (HA) C difﬁcile prevention methods imple-
mented over a 3-year period. First, the use of a multidisciplinary
prevention team of health care workers dedicated to C difﬁcile
prevention was assessed. Subsequently, PX-UV was implemented
as an enhanced disinfection measure.
METHODS
Baseline infection prevention and surveillance
This evaluation was conducted at an urban LTAC hospital in the
Southeastern United States. Most patient rooms contain a single
bed with a connected private bathroom. Per Centers for Disease
Control and Prevention guidelines, facility policy required contact
precautions and hand hygienewith soap andwater when caring for
patients with C difﬁcile. After discharge, rooms and bathrooms are
terminally cleaned with a sodium hypochlorite solution. C difﬁcile
infection rates were determined using the National Healthcare
Safety Network’s infection surveillance reporting criteria. Institu-
tional review board exemption was not sought because the
research used existing data. During the 12-month preintervention
period, no new infection prevention policies or protocols were
implemented.
Multidisciplinary team intervention
A multidisciplinary C difﬁcile prevention team was formed in
March 2011 and was comprised of staff members from pharmacy,
nursing, respiratory therapy, rehabilitation, dietary, laboratory,
environmental services, building maintenance, and infectious dis-
ease. Before the formation of the prevention team, efforts to control
the spread of C difﬁcile infection included increasing the visibility of
isolation signage using large and brightly colored signs, daily round
to assess compliance with isolation practices, re-education for staff
on the need for hand hygiene with soap and water when caring for
C difﬁcile patients, and implementation of disposable patient care
equipment in isolation rooms (blood pressure cuffs, stethoscopes,
and thermometers).
The multidisciplinary team reviewed available best practice
guidelines for prevention of C difﬁcile and implemented several
new processes in June 2011. An initial measure recommended by
the group was the installation of additional sinks on the nursing
units in an effort to increase compliance with soap and water hand
hygiene. Hand hygiene rates were monitored by hospital staff
throughout the study period, and compliance rates did not change
over time. Equipment disinfection was reinforced with staff, and
sodium hypochlorite wipes were made available in room housing
patients with C difﬁcile infection. Additional disposable equipment
was added for isolation rooms, including lift slings, wash basins and
bedside commode liners. The team identiﬁed the potential for
cross-contamination of mobile work stations and multiuse medi-
cation vials during the medication administration process. This was
combatted by eliminating the mobile work stations and installing a
permanent work station within each patient room. A checklist for
terminal cleaning was also implemented, which emphasized steps
to reduce cross-contamination during the disinfection process.Finally, clinical staff were re-educated on the signs of C difﬁcile
infection to ensure that patients were identiﬁed and isolated in a
timely manner.
PX-UV device
The PX-UV device (Xenex 426i; Xenex Disinfection Services, San
Antonio, TX) uses a high-voltage discharge capacitor connected to a
xenon ﬂash lamp to release high-intensity, polychromatic pulses of
UV light that cover the entire germicidal spectrum (210-280 nm).
This novel technology differs from other sources of UV disinfection,
which use low-pressure mercury lamps to produce monochromatic
UV light.14 The implementation of these devices has beenpreviously
described.15 The devices are designed to deliver UV light to surfaces
throughout the room, with a speciﬁc focus on high-touch surfaces.
Multiple disinfection positions are used to assure that surfaces are
not shadowed from the light. Information about each disinfection
cycle is logged by the device and uploaded to an online portal. These
data are used to assure that housekeeping staff are placing the robot
in the appropriate number of positions for the area they are dis-
infecting and to track theoverall usagewithin thehealth care facility.
PX-UV adjunct
One PX-UV device was deployed between July 2012 and
September 2014, in addition to the performance improvement
programs already implemented by the multidisciplinary team. The
PX-UV device was used speciﬁcally as an adjunct to standard
manual cleaning of patient areas. The usage goal across the LTAC
facility included all patient rooms after discharge and communal
living areas on a weekly basis, such as dining rooms, rehabilitation
areas, and lounges. Device usage was tracked using an on-board
data log. On average, the PX-UV device was used to disinfect 85
discharge rooms and communal living areas per month. Disinfec-
tion was primarily done in the communal living areas because of
the low discharge volume at the facility.
Statistical analysis
HA C difﬁcile infection rates for each intervention were
compared with infection rates of the directly previous intervention
period. Because of the nonparametric nature of our data, compar-
isons were made using a 2-sample Wilcoxon rank-sum test in Stata
Table 1
Hospital-acquired Clostridium difﬁcile infection rates by intervention period
Intervention Phase Intervention period Infection rate per 10,000 patient days (no. of cases) SD % reduction from previous period P value
No intervention July 2010- June 2011 23.3 (30) 19.64 NA NS
C difﬁcile team July 2011-June 2012 19.3 (23) 14.06 17.3 .91
PX-UV þ C difﬁcile team July 2012-September 2014 8.3 (22) 8.88 56.9 .02
NA, not applicable; PX-UV, pulsed-xenon ultraviolet light disinfection.
R. Miller et al. / American Journal of Infection Control 43 (2015) 1350-31352software version 12.1 (StataCorp, College Station, TX). The analysis
was sufﬁciently powered to detect differences between the inter-
vention groups.RESULTS
During the 12-month preintervention period, the HA C difﬁcile
infection rate was 23.3 per 10,000 patient days. On the addition of
the multidisciplinary team, the HA C difﬁcile infection rate dropped
17.3% to 19.3 per 10,000 patient days (P ¼ .91). PX-UV was then
implemented in July 2012 while the multidisciplinary team
approach continued (Fig 1). Over a 15-month period, infection rates
dropped 56.9% compared with the baseline year to 8.3 per 10,000
patient days (P ¼ .02) (Table 1). Based on these outcomes, it is pre-
dicted that the facilitywas able to prevent 29HAC difﬁcile infections
and generate over 210 additional patient bed days within the 15-
month intervention. At $13,500 in hospital care costs per case, this
could have potentially resulted in net savings of approximately
$300,000.16-23DISCUSSION
HA C difﬁcile rates during the use of PX-UV in conjunction with
the multidisciplinary team were lower than those rates during the
multidisciplinary team intervention alone. Based on the available
data, it is not possible to determine whether this impact is solely
from the addition of PX-UV or from a synergistic effect of the 2
interventions.
The use of PX-UV in the LTAC setting is very different from the
applications that have previously been reported in acute care set-
tings. Patients are discharged much less frequently from LTAC fa-
cilities; therefore, there is less daily demand for PX-UV for terminal
cleaning purposes. Rather, PX-UV was used in high-trafﬁc ancillary
and communal living areas. These areas provide an environment
where health care workers and patients regularly intermingle, and
there are frequent opportunities for environmental contamination
and transmission. These data show the potential of enhanced
disinfection for impacting the rates of C difﬁcile in LTAC facilities
and other facilities with different operational patterns than acute
care hospitals.
These ﬁndings further support the previous research impli-
cating the environment as a factor in the transmission of C difﬁcile.
Colonized and infected C difﬁcile patients will shed large numbers
of bacteria into the environment, and these bacteria can persist for
months. Because of extended length of stay, lower immune func-
tion of patients, and the communal nature of long-term care, it is
reasonable to expect that the exposure risk to C difﬁcile from the
environment is substantial in this care setting. While these results
demonstrate that no-touch disinfection could be successfully
implemented a single LTAC, more studies are needed to demon-
strate that this type of program can be replicated in other LTACs. It
may be useful for future research to perform environmental sam-
pling of the patient rooms and communal areas of LTAC facilities to
validate the assumption that the communal areas serve as an
important reservoir in this care setting.This study is inherently limited by the quasi-experimental
design. The nonrandomized design limits the ability to attribute
the reduction in HA C difﬁcile solely to the implementation of the
PX-UV device. However, these results are corroborated by previous
quasi-experimental studies showing reductions in infections after
the implementation of PX-UV. This research adds to the body of
evidence describing the effectiveness of PX-UV devices and dem-
onstrates that this technology can be successfully implemented in
the long-term care setting.References
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